PHARMACOKINETICS OF ANTICONVULSANTS IN PREGNANCY - ALTERATIONS IN PLASMA-PROTEIN BINDING

被引:88
作者
YERBY, MS
FRIEL, PN
MCCORMICK, K
KOERNER, M
VANALLEN, M
LEAVITT, AM
SELLS, CJ
YERBY, JA
机构
[1] MINCEP EPILEPSY CARE PA,MINNEAPOLIS,MN 55514
[2] GIBSON ECON TERMINAL SALES BLDG,SEATTLE,WA 98104
[3] UNIV WASHINGTON,CTR REG EPILEPSY CTR,DEPT NEUROL SURG,SEATTLE,WA 98195
[4] UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195
[5] UNIV WASHINGTON,CTR CHILD DEV & MENTAL RETARDAT,SEATTLE,WA 98195
关键词
Anticonvulsants; Epilepsy; Pharmacokinetics; Pregnancy;
D O I
10.1016/0920-1211(90)90042-T
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Anticonvulsant levels decline as pregnancy progress, even in the face of constant and, in some cases, increased dosages of medications. It has been suggested that this decline is responsible for the increase in seizure frequency seen in approximately one-third of the women with epilepsy who become pregnant. Changes in plasma protein binding may explain the declines in anticonvulsant concentrations during pregnancy. A prospective cohort study was designed to test this hypothesis. Carbamazepine, phenytoin and phenobarbital were studied. The mean total concentrations of all 3 drugs declined as pregnancy progressed, rising in the postpartum period. Free concentrations also declined, but did so significantly only for phenobarbital. The free fraction for all anticonvulsants studied rose significantly throughout pregnancy. Protein binding is significantly altered during pregnancy for all 3 drugs studied and appears to account for much of the decline in anticonvulsant concentrations seen in this condition. It is suggested that free rather than total drug concentrations be monitored in pregnant women with epilepsy. © 1990.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 16 条
[1]   COURSE AND OUTCOME OF PREGNANCY IN WOMEN WITH EPILEPSY [J].
BJERKEDA.T ;
BAHNA, SL .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1973, 52 (03) :245-248
[2]  
BURNETT CWF, 1946, J OBSTET GYN BRIT EM, V53, P539
[3]  
DAM M, 1977, CLIN PHARMACOKINET, V2, P427
[4]   PLASMA DRUG LEVEL MONITORING IN PREGNANCY [J].
EADIE, MJ ;
LANDER, CM ;
TYRER, JH .
CLINICAL PHARMACOKINETICS, 1977, 2 (06) :427-436
[5]  
FREUND JE, 1980, MATH STATISTICS
[6]  
HIGGINS TA, 1974, J IRISH MED ASSOC, V67, P317
[7]  
HIILESMAA VK, 1981, LANCET, V2, P165
[8]  
JANZ D, 1982, EPILEPSIA, V23, P853
[9]   ANTI-CONVULSANTS DURING PREGNANCY AND LACTATION - TRANS-PLACENTAL, MATERNAL AND NEONATAL PHARMACOKINETICS [J].
NAU, H ;
KUHNZ, W ;
EGGER, HJ ;
RATING, D ;
HELGE, H .
CLINICAL PHARMACOKINETICS, 1982, 7 (06) :508-543
[10]   PLASMA-PROTEIN BINDING OF DRUGS IN PREGNANCY [J].
PERUCCA, E ;
CREMA, A .
CLINICAL PHARMACOKINETICS, 1982, 7 (04) :336-352